Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized Controlled Trial Comparing the Efficacy, Safety and Tolerability of Two Formulations of Vaginal Micronized Progesterone

NCT05899010 is registered in ClinicalTrials.gov with Fundación Santiago Dexeus Font as lead sponsor.

NCT NCT05899010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05899010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized Controlled Trial Comparing the Efficacy, Safety and Tolerability of Two Formulations of Vaginal Micronized Progesterone
Lead sponsor
Fundación Santiago Dexeus Font
Phase
Phase 3
Overall status
Recruiting
Start date
July 5, 2023
Completion date
April 30, 2028
Enrollment
1,020 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility